REPEAT: Cannabis Wheaton Income Corp. Announces Closing of $100 Million Private Placement of Convertible Debenture Units

VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) ("Wheaton Income" or the "Company") is pleased to announce the closing of its previously disclosed private placement of convertible debenture units (the "Convertible Debenture Units") for total gross proceeds of $100,000,000 (the "Offering"). The … [Read more...]

Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent Covering RECORLEV™ (levoketoconazole) for the Treatment of Cushing’s Syndrome

DUBLIN, Ireland and TREVOSE, Pa., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that the United States Patent and Trademark Office (USPTO) has entered a Notice of … [Read more...]

Loop Industries Announces Strategic Initiative to Support evian’s Commitment to Adopt a Circular Approach to Plastic Usage

MONTREAL, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ:LOOP) (the “Company” or “Loop”), a leader in the sustainable plastic revolution, today announced a strategic initiative with evian® as part of a long-term Danone global partnership, to enable evian’s 100% “circular approach” to plastic usage by 2025.  In partnership with evian, Loop joins a respected … [Read more...]

The Joint Corp. Opens 400th Clinic

SCOTTSDALE, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager and franchisor of chiropractic clinics, reached 400 open clinics systemwide in January, 2018, having opened 41 net new franchised clinics during 2017. Peter Holt, President and Chief Executive Officer of The Joint Corp., said, “We are proud to achieve the 400th … [Read more...]

Immunovaccine Names Joseph Sullivan, Experienced Global Pharmaceutical and Vaccine Executive, as Senior Vice President, Business Development

HALIFAX, Nova Scotia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has appointed Joseph Sullivan to the newly created role of Senior Vice President, Business Development, effective January 22, 2018. Mr. Sullivan brings over 25 years of global pharmaceutical and vaccine … [Read more...]